Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease
Recruiting
N/A
Interventional Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 60 (estimated)
- Sponsor
- IRCCS Centro Neurolesi Bonino Pulejo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The GM-REHAB-2025 study aims to evaluate the impact of physiotherapy interventions using the C-Mill treadmill, with and without semi-immersive virtual reality, on gut microbiota and metabolic parameters in patients with Parkinson's disease. Three groups will be involved: one undergoing conventional physiotherapy, one treated with the C-Mill without virtual reality (VR), and one treated with C-Mill…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of PD according to the Movement Disorder Society Clinical
* Diagnostic Criteria for Parkinson's Disease
* Age comprised between 40 to 70 years
* Patients with moderate to advanced disease (2 ≤ Hoehn and Yahr classification grade ≤ 4)
* Individuals able to walk indepe…
Contacts
No contact information available.